Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Proprotein convertase subtilisin/kexin type 9 inhibitors ×

Proprotein convertase subtilisin/kexin type 9 inhibitors

This drug is selected. Its supporting articles are shown below.

Proprotein convertase subtilisin/kexin type 9 inhibitors2

Articles mentioning Proprotein convertase subtilisin/kexin type 9 inhibitors

2 articles · page 1 of 1

PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial

bmjopen · abstract · 2026-03-18 · 1 matching annotations

78.6%

PCSK9i Proprotein convertase subtilisin/kexin type 9 inhibitors acute coronary syndrome (ACS)NCT06791031 Biomedical Research Ethics Committee of West China Hospital of Sichuan University ACS

…randomised 1:1 to an early intensified lipid-lowering strategy (PCSK9i added to moderate-intensity statin) or guideline-directed medic…

Generalised cutaneous xanthomas: an early indicator of familial hypercholesterolaemia—diagnostic and therapeutic insights

bmjcr · abstract · 2026-01-05 · 1 matching annotations

94.0%

proprotein convertase subtilisin/kexin type 9 inhibitors familial hypercholesterolaemia statin therapy cutaneous xanthomas plastic surgery team